USNA vs. TRMD

Last updated Apr 2, 2026

Compare and contrast key facts about USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD).

Performance

USNA vs. TRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD). The values are adjusted to include any dividend payments, if applicable.

USNA vs. TRMD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
USNA USANA Health Sciences, Inc.	-12.28%	-45.31%	-33.04%	0.75%	-47.43%	31.26%	-1.85%	-33.28%	52.11%
TRMD TORM plc	46.83%	11.21%	-23.37%	31.64%	297.66%	12.91%	-25.94%	84.18%	-22.59%

Fundamentals

Market Cap USNA : $315.16M TRMD : $2.79B
EPS USNA : $0.59 TRMD : $2.85
PE Ratio USNA : 29.41 TRMD : 9.82
PS Ratio USNA : 0.34 TRMD : 2.10
PB Ratio USNA : 0.59 TRMD : 1.27
Total Revenue (TTM) USNA : $925.26M TRMD : $1.34B
Gross Profit (TTM) USNA : $724.41M TRMD : $582.69M
EBITDA (TTM) USNA : $71.30M TRMD : $580.07M

Returns By Period

In the year-to-date period, USNA achieves a -12.28% return, which is significantly lower than TRMD's 46.83% return.

USNA

• 1D: -1.43%
• 1M: -14.29%
• YTD: -12.28%
• 6M: -36.85%
• 1Y: -36.83%
• 3Y*: -35.07%
• 5Y*: -29.54%
• 10Y*: -11.88%

TRMD

• 1D: 0.39%
• 1M: -7.08%
• YTD: 46.83%
• 6M: 38.47%
• 1Y: 87.27%
• 3Y*: 12.60%
• 5Y*: 41.23%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

USNA vs. TRMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USNA

USNA Risk / Return Rank: 13
USNA Sharpe Ratio Rank: 8
USNA Sortino Ratio Rank: 10
USNA Omega Ratio Rank: 10
USNA Calmar Ratio Rank: 16
USNA Martin Ratio Rank: 18

TRMD

TRMD Risk / Return Rank: 90
TRMD Sharpe Ratio Rank: 92
TRMD Sortino Ratio Rank: 89
TRMD Omega Ratio Rank: 85
TRMD Calmar Ratio Rank: 92
TRMD Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USNA vs. TRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	USNA	TRMD	Difference
Sharpe ratio Return per unit of total volatility	-0.81	2.22	-3.04
Sortino ratio Return per unit of downside risk	-1.01	2.83	-3.84
Omega ratio Gain probability vs. loss probability	0.86	1.34	-0.48
Calmar ratio Return relative to maximum drawdown	-0.69	4.46	-5.15
Martin ratio Return relative to average drawdown	-1.15	11.70	-12.85
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

USNA vs. TRMD - Sharpe Ratio Comparison

The current USNA Sharpe Ratio is -0.81, which is lower than the TRMD Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of USNA and TRMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	USNA	TRMD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.81	2.22	-3.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.83	0.90	-1.74
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.31	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.10	0.48	-0.38

Correlation

The correlation between USNA and TRMD is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

USNA vs. TRMD - Dividend Comparison

USNA has not paid dividends to shareholders, while TRMD's dividend yield for the trailing twelve months is around 7.57%.

	TTM	2025	2024	2023	2022	2021	2020
USNA USANA Health Sciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TRMD TORM plc	7.57%	10.32%	30.13%	23.05%	6.99%	0.00%	14.89%

Drawdowns

USNA vs. TRMD - Drawdown Comparison

The maximum USNA drawdown since its inception was -94.90%, which is greater than TRMD's maximum drawdown of -60.59%. Use the drawdown chart below to compare losses from any high point for USNA and TRMD.

Drawdown Indicators

	USNA	TRMD	Difference
Max Drawdown Largest peak-to-trough decline	-94.90%	-60.59%	-34.31%
Max Drawdown (1Y) Largest decline over 1 year	-52.27%	-19.49%	-32.78%
Max Drawdown (5Y) Largest decline over 5 years	-84.11%	-60.59%	-23.52%
Max Drawdown (10Y) Largest decline over 10 years	-87.59%	—	—
Current Drawdown Current decline from peak	-87.36%	-13.10%	-74.26%
Average Drawdown Average peak-to-trough decline	-40.75%	-22.91%	-17.84%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.33%	7.43%	+23.90%

Volatility

USNA vs. TRMD - Volatility Comparison

The current volatility for USANA Health Sciences, Inc. (USNA) is 10.17%, while TORM plc (TRMD) has a volatility of 15.01%. This indicates that USNA experiences smaller price fluctuations and is considered to be less risky than TRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	USNA	TRMD	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.17%	15.01%	-4.84%
Volatility (6M) Calculated over the trailing 6-month period	37.53%	26.37%	+11.16%
Volatility (1Y) Calculated over the trailing 1-year period	45.52%	39.46%	+6.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.59%	45.88%	-10.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	38.31%	60.24%	-21.93%

Financials

USNA vs. TRMD - Profitability Comparison

The chart below illustrates the profitability comparison between USANA Health Sciences, Inc. and TORM plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

USNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, USANA Health Sciences, Inc. reported a gross profit of 200.79M and revenue of 226.20M. Therefore, the gross margin over that period was 88.8%.

TRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, TORM plc reported a gross profit of 134.80M and revenue of 354.98M. Therefore, the gross margin over that period was 38.0%.

USNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, USANA Health Sciences, Inc. reported an operating income of 3.82M and revenue of 226.20M, resulting in an operating margin of 1.7%.

TRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, TORM plc reported an operating income of 98.16M and revenue of 354.98M, resulting in an operating margin of 27.7%.

USNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, USANA Health Sciences, Inc. reported a net income of -1.78M and revenue of 226.20M, resulting in a net margin of -0.8%.

TRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, TORM plc reported a net income of 87.39M and revenue of 354.98M, resulting in a net margin of 24.6%.